Key result
Treatment with a beta blocker was effective in controlling symptoms and heart rate in a patient with new-onset POTS likely secondary to breast cancer chemotherapy.
Why the study?
POTS can occur as a new condition during chemotherapy for breast cancer, but awareness among clinicians is limited.
Case Report (n=1)
Postural orthostatic tachycardia syndrome (POTS) is a common condition of orthostatic intolerance in response to changes in position. We report a case of a middle-aged woman presenting with a new onset of POTS likely due to chemotherapy for treatment of breast cancer. She was started on a trial of a beta blocker, which was effective in controlling her symptoms and heart rate. The objective of this report was to encourage clinicians to consider POTS as a differential diagnosis, while managing patients with symptoms of orthostatic intolerance.
No takes yet. Share an insight, caveat, or question.
Babra et al. (2021) conducted a case report in Postural orthostatic tachycardia syndrome (POTS) in breast cancer (n=1). Beta blocker was evaluated on Symptom and heart rate control. Treatment with a beta blocker was effective in controlling symptoms and heart rate in a patient with new-onset POTS likely secondary to breast cancer chemotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: